Nephrotoxicity Related to New Therapeutic Compounds

REFERENCES

• Thadhani, R.; Pascual, M.; Bonventre, J V. Acute renal failure. N. Engl. J. Med. 1996, 334, 1448–1460. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Khan, K N.; Paulson, S K.; Verburg, K M.; Lefkowith, J B.; Maziasz, T J. Pharmacology of cyclooxygenase-2 inhibition in the kidney. Kidney Int. 2002, 61, 1210–1219. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Rossat, J.; Maillard, M.; Nussberger, J.; Brunner, H R.; Burnier, M. Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects. Clin. Pharmacol. Ther. 1999, 66, 7.6–84.
   Google Scholar
• Whelton, A.; Schulman, G.; Wallemark, C.; Drower, E J.; Isakson, P C.; Verburg, K M.; Geis, G S. Effects of celecoxib and naproxen on renal function in the elderly. Arch. Intern. Med. 2000, 160, 1465–1470. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Whelton, A.; Brater, D C.; Sica, D A. Effects of celecoxib and naproxen on renal function in chronic renal insufficiency patients [abstract]. J. Am. Soc. Nephrol. 1999, 10, 92A.
   Google Scholar
• Catella-Lawson, F.; McAdam, B.; Morrison, B W.; Kapoor, S.; Kujubu, D.; Antes, L.; Lasseter, K C.; Quan, H.; Gertz, B J.; Fitzgerald, G A. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. J. Pharmacol. Exp. Ther. 1999, 289, 735–741. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Swan, S K.; Rudy, D W.; Lasseter, K C.; Ryan, C F.; Buechel, K L.; Lambrecht, L J.; Pinto, M B.; Dilzer, S C.; Obrda, O.; Sundblad, K J.; Gumbs, C P.; Ebel, D L.; Quan, H.; Larson, P J.; Schwartz, J I.; Musliner, T A.; Gertz, B J.; Brater, D C.; Yao, S L. Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial. Annu. Intern. Med. 2000, 133, 1–9. [CSA]
   PubMed Web of Science ®Google Scholar
• Whelton, A.; Maurath, C J.; Verburg, K M.; Geis, G S. Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor. Am. J. Ther. 2000, 7, 159–175. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Chan, F K.; Hung, L C.; Suen, B Y.; Wu, J C.; Lee, K C.; Leung, V K.; Hui, A J.; To, K F.; Leung, W K.; Wong, V W.; Chung, S C.; Sung, J J. Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. N. Engl. J. Med. 2002, 347, 2104–2110. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Markowitz, G S.; Appel, G B.; Fine, P L.; Fenves, A Z.; Loon, N R.; Jagannath, S.; Kuhn, J A.; Dratch, A D.; D'agati, V D. Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. J. Am. Soc. Nephrol. 2001, 12, 1164–1172. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Markowitz, G S.; Fine, P L.; Stack, J I.; Kunis, C L.; Radhakrishnan, J.; Palecki, W.; Park, J.; Nasr, S H.; Hoh, S.; Siegel, D S.; D'agati, V D. Toxic acute tubular necrosis following treatment with zoledronate (Zometa). Kidney Int. 2003, 64, 281–289. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• De Clercq, E. Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections. Clin. Microbiol. Rev. 2003, 16, 569–596. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Tanji, N.; Tanji, K.; Kambham, N.; Markowitz, G S.; Bell, A.; D'agati, V D. Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion. Human Pathol. 2001, 32, 734–740. [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ho, E S.; Lin, D C.; Mendel, D B.; Cihlar, T. Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. J. Am. Soc. Nephrol. 2000, 11, 383–393. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kopp, J B.; Miller, K D.; Mican, J A.; Feuerstein, I M.; Vaughan, E.; Baker, C.; Pannell, L K.; Falloon, J. Crystalluria and urinary tract abnormalities associated with indinavir. Annu. Intern. Med. 1997, 127, 119–125. [CSA]
   PubMed Web of Science ®Google Scholar
• Gagnon, R F.; Tecimer, S N.; Watters, A K.; Tsoukas, C M. Prospective study of urinalysis abnormalities in HIV-positive individuals treated with indinavir. Am. J. Kidney Dis. 2000, 36, 507–515. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Herman, J S.; Ives, N J.; Nelson, M.; Gazzard, B G.; Easterbrook, P J. Incidence and risk factors for the development of indinavir-associated renal complications. J. Antimicrob. Chemother. 2001, 48, 355–360. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Perazella, M A. Crystal-induced acute renal failure. Am. J. Med. 1999, 106, 459–465. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Cayco, A V.; Perazella, M A.; Hayslett, J P. Renal insufficiency after intravenous immune globulin therapy: a report of two cases and an analysis of the literature. J. Am. Soc. Nephrol. 1997, 8, 1788–1794. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Tsinalis, D.; Dickenmann, M.; Brunner, F.; Gurke, L.; Mihatsch, M.; Nickeleit, V. Acute renal failurein a renal allograft recipient treated with intravenous immunoglobulin. Am. J. Kidney Dis. 2002, 40, 667–670. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Schortgen, F.; Lacherade, J C.; Bruneel, F.; Cattaneo, I.; Hemery, F.; Lemaire, F.; Brochard, L. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001, 357, 911–916. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• De Labarthe, A.; Jacobs, F.; Blot, F.; Glotz, D. Acute renal failure secondary to hydroxyethylstarch administration in a surgical patient. Am. J. Med. 2001, 111, 417–418. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar